Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
AOAExcel Endorses Barti Software as First Eye Care EHR
AOAExcel, a for-profit subsidiary and member-benefit arm of the American Optometric Association (AOA), has announced its first-ever endorsement of an Electronic Health Records (EHR) system—Barti Software. This partnership includes a financial investment in the San Francisco-based EHR provider, marking a…
The use of artificial intelligence based chat bots in ophthalmology triage – Nature
The use of artificial intelligence based chat bots in ophthalmology triage Nature Source: Author: | Date: 2024-11-26 08:00:00 Source: Author: | Date: 2024-11-26 08:00:00
Avirmax Launches ABI-110 Gene Therapy Trial for Wet AMD
Avirmax Biopharma has reached a major milestone in its mission to revolutionize the treatment of wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) by successfully dosing the first patient in the phase I/IIa clinical trial of ABI-110, the…
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 19, a comparative study of the cost and carbon footprint of local anaesthesia techniques for cataract surgery | Eye – Nature
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 19, a comparative study of the cost and carbon footprint of local anaesthesia techniques for cataract surgery | Eye Nature Source: Author: | Date: 2024-11-23 08:00:00 Source: Author:…
USC Receives $6M Grant for Dry AMD Therapy
The California Institute for Regenerative Medicine (CIRM) has awarded a $6 million, two-year grant to researchers at the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics and the USC Roski Eye Institute. This funding will advance preclinical studies…
EO2002: Non-Surgical Solution for Corneal Edema
Emmecell has announced positive results from its U.S. multicenter Phase 1 trial evaluating EO2002, an innovative non-surgical cell therapy for corneal edema. The randomized, double-masked trial demonstrated significant improvements in best corrected visual acuity (BCVA) and reductions in central corneal…
Positive Phase 3 Results for MELT-300 Sedation
Melt Pharmaceuticals has reported promising topline results from the pivotal Phase 3 trial of MELT-300, a novel, non-intravenous, non-opioid sedation tablet developed for use during cataract surgeries. The study, conducted under an FDA-approved Special Protocol Assessment (SPA) agreement, demonstrated that…
Ocugen Shares Positive OCU410 Trial Results for GA
Ocugen has released encouraging preliminary findings from the Phase 1 portion of its Phase 1/2 OCU410 ArMaDa clinical trial, focused on treating geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The results demonstrate the potential of OCU410 as…
Strategies on How Reduce Eye Pressure Instantly
What Is Intraocular Pressure? Eye pressure, also known as intraocular pressure (IOP), is a critical factor in maintaining the health of your eyes. Elevated eye pressure can lead to various eye conditions, including glaucoma, which can result in permanent vision…
FDA Awards Designations to Gildeuretinol for Stargardt
Key Takeaways • Gildeuretinol (ALK-001) has received Rare Pediatric Disease and Fast Track designations, alongside prior Breakthrough Therapy and Orphan Drug statuses, emphasizing its potential to transform treatment for Stargardt disease. • Data from the TEASE-1…